A Phase Ib/II, Open-label, Multicenter Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma
Latest Information Update: 07 Apr 2022
At a glance
- Drugs Binimetinib (Primary) ; Sotrastaurin (Primary)
- Indications Uveal melanoma
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- Sponsors Novartis
- 06 Apr 2022 This trial has been completed in Netherland (Global end date: 15/05/2015), according to European Clinical Trials Database record.
- 21 Jul 2015 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
- 02 Jun 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.